Inhibition of ataxia telangiectasia related-3 (ATR) improves therapeutic index in preclinical models of non-small cell lung cancer (NSCLC) radiotherapy

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)
315 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Inhibition of ataxia telangiectasia related-3 (ATR) improves therapeutic index in preclinical models of non-small cell lung cancer (NSCLC) radiotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences